Anuh Pharma Ltd Financials
Company Logo

Anuh Pharma Ltd Financial Statement

Anuh Pharma Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Sep 2024
Revenue169.35
Operating Expense149.07
Net Profit15.04
Net Profit Margin8.88
Earning Per Share3.00
EBIDTA21.11
Effective Tax Rate19.67
Invest in Anuh Pharma Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions

Anuh Pharma Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual647.00
Operating Expenses Annual571.86
Operating Profit Annual87.25
Interest Annual0.35
Depreciation8.58
Net Profit Annual60.06
Tax Annual18.25

Anuh Pharma Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning1.93
Cash Flow from Operations12.93
Cash Flow from Investing0.92
Cash Flow from Financing-8.57
Cash Flow at the End7.20

Anuh Pharma Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)11.92
PBIT Margin (%)10.60
PBT Margin (%)-0.44
Net PROFIT Margin (%)9.28
Return On Networth / Equity (%)19.49
Return On Networth /Employed (%)25.44
Return On Assets (%)22.28
Total Debt / Equity (X)0.01
Asset Turnover Ratio (%)2.40

Anuh Pharma Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual48.95
Total Current Assets Annual336.20
Non Current Assets Annual109.48
Total Shareholders Funds Annual291.22
Total Assets Annual445.68

Anuh Pharma Ltd Earning Calls

No Data Availabe

Get Your FAQs Right

As of Nov 23, 2024, Anuh Pharma Ltd has a market capitalization of 1,230.75 Cr. Value Research classifies it as a Small-Cap company.
Yes, Anuh Pharma Ltd is debt-free with a debt-to-equity ratio of 0.01.
In FY 2023 , Anuh Pharma Ltd recorded a total revenue of approximately 647 Cr marking a significant milestone in the company's financial performance.
Anuh Pharma Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.5% and 0.1% annually, respectively..
Anuh Pharma Ltd's current PE ratio is 20.49.
Anuh Pharma Ltd's ROCE averaged 21.6% from the FY ending March 2022 to 2024, with a median of 19.7%. It peaked at 26.8% in March 2024, reflecting strong capital efficiency over the period..
Anuh Pharma Ltd's latest EBIT is Rs. 78.66 Cr, surpassing the average EBIT of Rs. 55.48 Cr over the 5 years..